Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × Focal Adhesion Protein-Tyrosine Kinases × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Immunoglobulin Light-chain Amyloidosis 3 Multiple Myeloma 1

Interventions

Dexamethasone 220 Lenalidomide 138 daratumumab 117 Bortezomib 89 pomalidomide 79 Calcium Dobesilate 71 carfilzomib 67 Cyclophosphamide 65 Specimen Handling 37 Biopsy 37 belantamab mafodotin 35 fludarabine 32 isatuximab 31 Magnetic Resonance Spectroscopy 31 dexamethasone acetate 29 dexamethasone 21-phosphate 29 auricularum 28 talquetamab 27 Melphalan 27 ixazomib 24 iberdomide 22 elotuzumab 19 selinexor 17 fludarabine phosphate 16 Whole-Body Irradiation 12 X-Rays 11 Stem Cell Transplantation 11 tocilizumab 10 Standard of Care 10 venetoclax 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05695508 2025-12-24

HD10/DSMMXX

University of Heidelberg Medical Center

Phase 2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡